首页|腹腔镜下胃癌根治术联合胃转流术治疗胃癌合并2型糖尿病

腹腔镜下胃癌根治术联合胃转流术治疗胃癌合并2型糖尿病

扫码查看
目的:探讨腹腔镜下胃癌根治术联合胃转流术治疗胃癌合并2型糖尿病患者的临床疗效及安全性。方法回顾性分析接受腹腔镜胃癌根治术联合胃转流术治疗4例2型糖尿病患者的临床资料。结果4例患者均完成腹腔镜下胃癌根治联合胃转流术,手术顺利,无中转开放,术后未发生严重并发症。术前空腹血糖(FPG)6.6-9.0mmol/L,平均8.1mmol/L;糖化血红蛋白(HbAlC)6.8%-9.5%,平均7.8%。术后 l -12个月复查 FPG4.8-7.9mmoL/L,平均6.4mmoL/L;HbAlC5.5%-7.2%,平均6.3%。据美国糖尿病协会(ADA)糖尿病疗效判断标准,3例治愈,1例改善。结论腹腔镜下胃癌根治术联合胃转流术对胃癌合并2型糖尿病患者临床疗效显著,能有效治疗2型糖尿病,手术安全可行。
Laparoscopic Aastrectomy for Gastric cancer and Roux-en Y Gastric Bypass on type 2 Diabetes Mellitus
Objective To investigate the Clinical efficacy and safety of the Laparoscopic gastrectomy for gastric cancer and Roux -en Y gastric bypass on type 2 di-abetes mellitus.Method Retrospectively analyzed the clinical data of 4 patients under the laparoscopic gastrectomy for gastric cancer in combination with the Roux -en Y gastric bypass on type 2 diabetes mellitus.Result Four patients all completed accomplishes the Laparoscopic gastrectomy for gastric cancer and Roux -en Y gastric by-pass on type 2 diabetes mellitus.Operation smoothly,no opening,no postoperative serious complications occurred.Preoperative fasting plasma glucose(FPG)was 6.6-9. 0 mmoL/L,the average data was8.1mmol/L Glycosylated hemoglobin(HbAlC)was 6.8%-9.5%,the average data was 7.8%.after review 1-12 months,FPG was4. 8-7.9 mmoL/L,the average data was 6.4 mmoL/L,HbAlC 5.5%7.2%,the average data was 6.3%.According to the American diabetes association(ADA)curative effect judgment standard,3 cases were cured,1 case of improvement.Conclusion The Clinical efficacy and safety of the Laparoscopic gastrectomy for gastric cancer and Roux-en Y gastric bypass on type 2 diabetes mellitus was significantly.Can effectively treat type 2 diabetes,the operation safety is feasible.

LaparoscopicGastric cancerRoux-en Y gastric bypass type2 diabetes mellitus

郭浩、胡远超、田庆中

展开 >

徐州市中心医院肿瘤外科,江苏 徐州 221009

腹腔镜 胃癌 胃转流术 2型糖尿病

2014

中国保健营养(下旬刊)
全国卫生产业企业管理协会

中国保健营养(下旬刊)

ISSN:1004-7484
年,卷(期):2014.(5)
  • 2
  • 7